BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 434454)

  • 1. Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity.
    Cousins MJ; Sharp JH; Gourlay GK; Adams JF; Haynes WD; Whitehead R
    Anaesth Intensive Care; 1979 Feb; 7(1):9-24. PubMed ID: 434454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An animal model of hepatotoxicity associated with halothane anesthesia.
    Sipes IG; Brown BR
    Anesthesiology; 1976 Dec; 45(6):622-8. PubMed ID: 984478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia.
    McLain GE; Sipes IG; Brown BR
    Anesthesiology; 1979 Oct; 51(4):321-6. PubMed ID: 484893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in halothane metabolism and hepatotoxicity in a rat model.
    Plummer JL; Hall PM; Jenner MA; Cousins MJ
    Anesth Analg; 1985 Jun; 64(6):563-9. PubMed ID: 4003773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halothane hepatitis in an animal model: time course of hepatic damage.
    Knights KM; Gourlay GK; Hall PD; Adams JF; Cousins MJ
    Br J Exp Pathol; 1987 Oct; 68(5):613-24. PubMed ID: 3689669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the requirements for hepatic injury with halothane and enflurane in rats.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR
    Anesth Analg; 1985 Oct; 64(10):955-63. PubMed ID: 4037395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic differences in reductive metabolism and hepatotoxicity of halothane in three rat strains.
    Gourlay GK; Adams JF; Cousins MJ; Hall P
    Anesthesiology; 1981 Aug; 55(2):96-103. PubMed ID: 7258721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respective roles of hypoxia and halothane metabolism in halothane-induced liver injury in rats.
    Hatano H; Nomura F; Ohnishi K; Iijima T; Hayasaka A; Iida S; Koen H; Okuda K
    Hepatology; 1985; 5(2):241-4. PubMed ID: 3979956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane.
    Sipes IG; Gandolfi AJ; Pohl LR; Krishna G; Brown BR
    J Pharmacol Exp Ther; 1980 Sep; 214(3):716-20. PubMed ID: 7400974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halothane hepatotoxicity and reductive metabolism of halothane in acute experimental liver injury in rats.
    Nomura F; Hatano H; Iida S; Ohnishi K
    Anesth Analg; 1988 May; 67(5):448-52. PubMed ID: 3364763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR; Waters SJ
    Anesth Analg; 1986 Aug; 65(8):835-9. PubMed ID: 3729018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia.
    Lunam CA; Cousins MJ; Hall PD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):802-9. PubMed ID: 3973829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent binding of oxidative biotransformation intermediates is associated with halothane hepatotoxicity in guinea pigs.
    Lind RC; Gandolfi AJ; Hall PD
    Anesthesiology; 1990 Dec; 73(6):1208-13. PubMed ID: 2248397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and halothane metabolism in vivo: release of inorganic fluoride and halothane metabolite binding to cellular constituents.
    Widger LA; Gandolfi AJ; Van Dyke RA
    Anesthesiology; 1976 Mar; 44(3):197-201. PubMed ID: 1267885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halothane hepatotoxicity and the reduced derivative, 1,1,1-trifluoro-2-chloroethane.
    Brown BR; Sipes IG; Baker RK
    Environ Health Perspect; 1977 Dec; 21():185-8. PubMed ID: 612444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halothane hepatotoxicity in glutathione depleted rats.
    Wilhelm KP; Younes M; Sellin D; Siegers CP
    J Appl Toxicol; 1987 Apr; 7(2):105-10. PubMed ID: 3624765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-course of formation of volatile reductive metabolites of halothane in humans and an animal model.
    Gourlay GK; Adams JF; Cousins MJ; Sharp JH
    Br J Anaesth; 1980 Mar; 52(3):331-6. PubMed ID: 7370149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of oxidative biotransformation of halothane in the guinea pig model of halothane-associated hepatotoxicity.
    Lind RC; Gandolfi AJ; Hall PD
    Anesthesiology; 1989 Apr; 70(4):649-53. PubMed ID: 2930002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halothane hepatotoxicity and fluoride production in mice and rats.
    Gorsky BH; Cascorbi HF
    Anesthesiology; 1979 Feb; 50(2):123-5. PubMed ID: 434485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cimetidine and ranitidine on halothane metabolism and hepatotoxicity in an animal model.
    Plummer JL; Wanwimolruk S; Jenner MA; Hall PD; Cousins MJ
    Drug Metab Dispos; 1984; 12(1):106-10. PubMed ID: 6141900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.